bpc-157 unapproved new drug fda Panel Divided Over Peptide Compounding FDA advisers back broad access

Some prominent figures in the health optimization space have reported personal benefits including pain elimination from spinal compression after just two injections, though these represent uncontrolled single-person reports rather than systematic evidence

RENEW is the planned monotherapy Phase 3 program

Helpful context before the funnel FormBlends Editorial Context Reviewed May 14, 2026 Compare three next-gen weight loss drugs: Retatrutide (24% weight loss), CagriSema (17.5% loss), and Survodutide (18.9% loss)

The peptides mechanism of action involves activating telomerase, an enzyme that protects telomeres (the ends of chromosomes) from shortening